187 related articles for article (PubMed ID: 15781121)
1. Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias.
Anderson ME
Pharmacol Ther; 2005 Apr; 106(1):39-55. PubMed ID: 15781121
[TBL] [Abstract][Full Text] [Related]
2. Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy.
Khoo MS; Li J; Singh MV; Yang Y; Kannankeril P; Wu Y; Grueter CE; Guan X; Oddis CV; Zhang R; Mendes L; Ni G; Madu EC; Yang J; Bass M; Gomez RJ; Wadzinski BE; Olson EN; Colbran RJ; Anderson ME
Circulation; 2006 Sep; 114(13):1352-9. PubMed ID: 16982937
[TBL] [Abstract][Full Text] [Related]
3. Calmodulin kinase and L-type calcium channels; a recipe for arrhythmias?
Anderson ME
Trends Cardiovasc Med; 2004 May; 14(4):152-61. PubMed ID: 15177266
[TBL] [Abstract][Full Text] [Related]
4. Calmodulin kinase II inhibition shortens action potential duration by upregulation of K+ currents.
Li J; Marionneau C; Zhang R; Shah V; Hell JW; Nerbonne JM; Anderson ME
Circ Res; 2006 Nov; 99(10):1092-9. PubMed ID: 17038644
[TBL] [Abstract][Full Text] [Related]
5. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.
Ai X; Curran JW; Shannon TR; Bers DM; Pogwizd SM
Circ Res; 2005 Dec; 97(12):1314-22. PubMed ID: 16269653
[TBL] [Abstract][Full Text] [Related]
6. CaM kinase inhibition: apply directly to the heart?
London B
Circ Res; 2006 Nov; 99(10):1027-8. PubMed ID: 17095730
[No Abstract] [Full Text] [Related]
7. QT interval prolongation and arrhythmia: an unbreakable connection?
Anderson ME
J Intern Med; 2006 Jan; 259(1):81-90. PubMed ID: 16336516
[TBL] [Abstract][Full Text] [Related]
8. The role of calmodulin kinase II in myocardial physiology and disease.
Couchonnal LF; Anderson ME
Physiology (Bethesda); 2008 Jun; 23():151-9. PubMed ID: 18556468
[TBL] [Abstract][Full Text] [Related]
9. Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure.
Zhang T; Brown JH
Cardiovasc Res; 2004 Aug; 63(3):476-86. PubMed ID: 15276473
[TBL] [Abstract][Full Text] [Related]
10. Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart.
Maier LS; Bers DM
Cardiovasc Res; 2007 Mar; 73(4):631-40. PubMed ID: 17157285
[TBL] [Abstract][Full Text] [Related]
11. Multiple downstream proarrhythmic targets for calmodulin kinase II: moving beyond an ion channel-centric focus.
Anderson ME
Cardiovasc Res; 2007 Mar; 73(4):657-66. PubMed ID: 17254559
[TBL] [Abstract][Full Text] [Related]
12. Derepression of pathological cardiac genes by members of the CaM kinase superfamily.
McKinsey TA
Cardiovasc Res; 2007 Mar; 73(4):667-77. PubMed ID: 17217938
[TBL] [Abstract][Full Text] [Related]
13. Distinct roles of CaM and Ca(2+)/CaM -dependent protein kinase II in Ca(2+) -dependent facilitation and inactivation of cardiac L-type Ca(2+) channels.
Nie HG; Hao LY; Xu JJ; Minobe E; Kameyama A; Kameyama M
J Physiol Sci; 2007 Jun; 57(3):167-73. PubMed ID: 17511897
[TBL] [Abstract][Full Text] [Related]
14. CaMKII, an emerging molecular driver for calcium homeostasis, arrhythmias, and cardiac dysfunction.
Grueter CE; Colbran RJ; Anderson ME
J Mol Med (Berl); 2007 Jan; 85(1):5-14. PubMed ID: 17119905
[TBL] [Abstract][Full Text] [Related]
15. CaMKII and its role in cardiac arrhythmia.
Erickson JR; Anderson ME
J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1332-6. PubMed ID: 18803570
[TBL] [Abstract][Full Text] [Related]
16. Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy.
Wu Y; Temple J; Zhang R; Dzhura I; Zhang W; Trimble R; Roden DM; Passier R; Olson EN; Colbran RJ; Anderson ME
Circulation; 2002 Sep; 106(10):1288-93. PubMed ID: 12208807
[TBL] [Abstract][Full Text] [Related]
17. Calmodulin kinase II inhibition protects against structural heart disease.
Zhang R; Khoo MS; Wu Y; Yang Y; Grueter CE; Ni G; Price EE; Thiel W; Guatimosim S; Song LS; Madu EC; Shah AN; Vishnivetskaya TA; Atkinson JB; Gurevich VV; Salama G; Lederer WJ; Colbran RJ; Anderson ME
Nat Med; 2005 Apr; 11(4):409-17. PubMed ID: 15793582
[TBL] [Abstract][Full Text] [Related]
18. Targeting of a novel Ca+2/calmodulin-dependent protein kinase II is essential for extracellular signal-regulated kinase-mediated signaling in differentiated smooth muscle cells.
Marganski WA; Gangopadhyay SS; Je HD; Gallant C; Morgan KG
Circ Res; 2005 Sep; 97(6):541-9. PubMed ID: 16109919
[TBL] [Abstract][Full Text] [Related]
19. Ca2+/calmodulin-dependent protein kinase: a key component in the contractile recovery from acidosis.
Mattiazzi A; Vittone L; Mundiña-Weilenmann C
Cardiovasc Res; 2007 Mar; 73(4):648-56. PubMed ID: 17222810
[TBL] [Abstract][Full Text] [Related]
20. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury.
Vila-Petroff M; Salas MA; Said M; Valverde CA; Sapia L; Portiansky E; Hajjar RJ; Kranias EG; Mundiña-Weilenmann C; Mattiazzi A
Cardiovasc Res; 2007 Mar; 73(4):689-98. PubMed ID: 17217936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]